Misonix Expands BoneScalpel Portfolio

There’s a new addition to Misonix Inc.’s BoneScalpel family.

The company has released its newly developed 25-millimeter blade, a tool that enables surgeons to access previously unreachable anatomy and facilitates the cutting and removal of larger boney structures.

“We are excited to add this new blade to our portfolio of solutions for the BoneScalpel system,” President/CEO Michael A. McManus Jr. said. “We specifically developed the new 25mm blade in response to our surgeon customers needs to enable the completion of procedures not previously possible. We continue to work with surgeons from around the world to identify new opportunities to further expand the clinical utility of BoneScalpel.”

The BoneScalpel is an ultrasonic bone-cutting instrument that provides surgeons a clean, controlled bone incision and removal that is also soft-tissue sparing.  

“I have used the BoneScalpel extensively over the past several years and I view this technology as a vital piece of equipment for both standard laminectomies and more extensive osteotomies,” said Paul J. Holman, M.D., director at the Neurosurgical Spine Center, Houston Methodist Department of Neurosurgery in Houston, Texas. “The BoneScalpel allows for rapid, safe removal of bone with a reduction in bleeding. The new 25mm blade is an important addition to the choice of available tips. The extra length allows me to use the BoneScalpel for rapid bone removal during complex procedures such as pedicle subtraction osteotomies and vertebrectomies. The amount of local bone that is retained for fusion by using the BoneScalpel is also quite remarkable.”

Based in Farmingdale, N.Y., Misonix designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Addressing a combined market estimated to be worth more than $1.5 billion annually, Misonix’s proprietary ultrasonic medical devices are used in spine surgery, neurosurgery, orthopedic surgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications.